Hims & Hers Chief Legal Officer Sells Shares Under Pre-Set Trading Plan
Soleil Boughton, Chief Legal Officer at Hims & Hers Health (NYSE:HIMS), sold 6,236 shares in a transaction valued at $173,735. The sale was conducted under a Rule 10b5-1 trading plan established on May 21, 2026, which allows insiders to execute trades based on predetermined instructions. This structured approach suggests the decision wasn't reactive but part of an ongoing strategy. Boughton still holds over 304,270 shares directly, representing a $8.5 million stake in Hims & Hers as of September 16, 2026. The company's stock has declined by more than 50% year-to-date and is down significantly since the transaction date. Despite this, Boughton’s continued ownership indicates alignment with long-term performance. Hims & Hers Health operates a digital health platform generating $2.6 billion in trailing twelve-month revenue but reported a net loss of $142 million for that period.
Tickers: $HIMS
Topics: executive sale Hims & Hers Health Rule 10b5-1 trading plan